These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 28067724)
21. Characteristics of central serous chorioretinopathy complicated by focal choroidal excavation. Suzuki M; Gomi F; Hara C; Sawa M; Nishida K Retina; 2014 Jun; 34(6):1216-22. PubMed ID: 24240563 [TBL] [Abstract][Full Text] [Related]
22. Changes in choroidal thickness after systemic administration of high-dose corticosteroids: a pilot study. Han JM; Hwang JM; Kim JS; Park KH; Woo SJ Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):440-5. PubMed ID: 24370828 [TBL] [Abstract][Full Text] [Related]
23. Subfoveal choroidal thickness as a predictor of central serous chorioretinopathy. Ambiya V; Yogi R; Li A; Shah S; Sarvaiya C; Mehta P; Meyerele C; Wu L; Singh R; Banker A; Chhablani J Eye (Lond); 2016 Dec; 30(12):1623-1629. PubMed ID: 27689964 [TBL] [Abstract][Full Text] [Related]
24. Choroidal Changes at the Leakage Site in Acute Central Serous Chorioretinopathy. Sahoo NK; Maltsev DS; Goud A; Kulikov AN; Chhablani J Semin Ophthalmol; 2019; 34(5):380-385. PubMed ID: 31257974 [No Abstract] [Full Text] [Related]
25. Central serous chorioretinopathy in elderly subjects: angiographic and tomographic characteristics. Bae K; Nam SW; Kang SW; Kim ES; Yu SY; Kim KT; Kim SJ Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):279-288. PubMed ID: 30564905 [TBL] [Abstract][Full Text] [Related]
26. Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography. Fujimoto H; Gomi F; Wakabayashi T; Sawa M; Tsujikawa M; Tano Y Ophthalmology; 2008 Sep; 115(9):1494-500, 1500.e1-2. PubMed ID: 18394706 [TBL] [Abstract][Full Text] [Related]
27. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Maruko I; Iida T; Sugano Y; Ojima A; Ogasawara M; Spaide RF Ophthalmology; 2010 Sep; 117(9):1792-9. PubMed ID: 20472289 [TBL] [Abstract][Full Text] [Related]
28. Focal choroidal excavation in eyes with central serous chorioretinopathy. Ellabban AA; Tsujikawa A; Ooto S; Yamashiro K; Oishi A; Nakata I; Miyake M; Akagi-Kurashige Y; Ueda-Arakawa N; Arichika S; Yoshitake S; Takahashi A; Yoshimura N Am J Ophthalmol; 2013 Oct; 156(4):673-83. PubMed ID: 23831223 [TBL] [Abstract][Full Text] [Related]
29. OCT Angiography Compared to Fluorescein and Indocyanine Green Angiography in Chronic Central Serous Chorioretinopathy. Teussink MM; Breukink MB; van Grinsven MJ; Hoyng CB; Klevering BJ; Boon CJ; de Jong EK; Theelen T Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5229-37. PubMed ID: 26244299 [TBL] [Abstract][Full Text] [Related]
30. Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients. Ersoz MG; Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M Br J Ophthalmol; 2019 Jun; 103(6):725-729. PubMed ID: 30002072 [TBL] [Abstract][Full Text] [Related]
31. Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration. Fung AT; Yannuzzi LA; Freund KB Retina; 2012 Oct; 32(9):1829-37. PubMed ID: 22850219 [TBL] [Abstract][Full Text] [Related]
32. EN FACE IMAGING OF PACHYCHOROID SPECTRUM DISORDERS WITH SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY. Dansingani KK; Balaratnasingam C; Naysan J; Freund KB Retina; 2016 Mar; 36(3):499-516. PubMed ID: 26335436 [TBL] [Abstract][Full Text] [Related]
33. Clinical experience with eplerenone to treat chronic central serous chorioretinopathy. Cakir B; Fischer F; Ehlken C; Bühler A; Stahl A; Schlunck G; Böhringer D; Agostini H; Lange C Graefes Arch Clin Exp Ophthalmol; 2016 Nov; 254(11):2151-2157. PubMed ID: 27145785 [TBL] [Abstract][Full Text] [Related]
34. Pachychoroid neovasculopathy: aspect on optical coherence tomography angiography. Azar G; Wolff B; Mauget-Faÿsse M; Rispoli M; Savastano MC; Lumbroso B Acta Ophthalmol; 2017 Jun; 95(4):421-427. PubMed ID: 27597633 [TBL] [Abstract][Full Text] [Related]
36. Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy. Shinojima A; Kawamura A; Mori R; Fujita K; Yuzawa M Retina; 2011 Oct; 31(9):1912-20. PubMed ID: 21952105 [TBL] [Abstract][Full Text] [Related]
37. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy. Maruko I; Iida T; Sugano Y; Ojima A; Sekiryu T Retina; 2011 Sep; 31(8):1603-8. PubMed ID: 21487334 [TBL] [Abstract][Full Text] [Related]